Financial reports
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q1
Quarterly report
3 Aug 23
10-K/A
2022 FY
Annual report (amended)
23 Jun 23
10-K/A
2021 FY
Annual report (amended)
23 Jun 23
10-K/A
2020 FY
Annual report (amended)
23 Jun 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
Current reports
8-K
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
27 Feb 24
8-K
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7 Nov 23
8-K
Departure of Directors or Certain Officers
2 Oct 23
8-K
Regulation FD Disclosure
22 Aug 23
8-K
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
3 Aug 23
8-K
Entry into a Material Definitive Agreement
10 Jul 23
8-K
Amendments to Articles of Incorporation or Bylaws
9 Jun 23
8-K
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
15 May 23
8-K
Departure of Directors or Certain Officers
5 Apr 23
8-K
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
9 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
27 Feb 24
S-3
Shelf registration
27 Feb 24
S-8
Registration of securities for employees
9 Mar 23
424B5
Prospectus supplement for primary offering
18 Jan 23
424B5
Prospectus supplement for primary offering
17 Jan 23
424B5
Prospectus supplement for primary offering
16 Aug 22
424B5
Prospectus supplement for primary offering
15 Aug 22
424B5
Prospectus supplement for primary offering
9 May 22
POS EX
Additional exhibits for listing
9 May 22
POS AM
Prospectus update (post-effective amendment)
3 Mar 22
Proxies
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
18 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
Other
EFFECT
Notice of effectiveness
29 Apr 22
SEC STAFF
SEC staff action: Order
22 Mar 21
SEC STAFF
SEC staff action: Order
22 Feb 21
EFFECT
Notice of effectiveness
18 Aug 20
EFFECT
Notice of effectiveness
13 Aug 20
CORRESP
Correspondence with SEC
13 Aug 20
UPLOAD
Letter from SEC
12 Aug 20
EFFECT
Notice of effectiveness
8 Jul 20
CORRESP
Correspondence with SEC
24 Jun 20
UPLOAD
Letter from SEC
24 Jun 20
Ownership
4
Patrick Taylor Horn
20 Mar 24
3
Patrick Taylor Horn
20 Mar 24
4
Greg Tourangeau
8 Mar 24
144
Notice of proposed sale of securities
8 Mar 24
4
Alex Sapir
5 Mar 24
SC 13G/A
RA CAPITAL MANAGEMENT, L.P.
14 Feb 24
SC 13G/A
Third Rock Ventures III, L.P.
14 Feb 24
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 24
SC 13G/A
SUVRETTA CAPITAL MANAGEMENT, LLC
13 Feb 24
SC 13G/A
FMR LLC
9 Feb 24